a late stage cell therapy company, which engages in the development of autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.
Industry Biotechnology
A.I.dvisor tells us that PSTV and DRUG have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PSTV and DRUG's prices will move in lockstep.
Ticker / NAME | Correlation To PSTV | 1D Price Change % | ||
---|---|---|---|---|
PSTV | 100% | +2.86% | ||
DRUG - PSTV | 33% Poorly correlated | -3.20% | ||
ZYME - PSTV | 28% Poorly correlated | +2.12% | ||
ARRY - PSTV | 27% Poorly correlated | +0.36% | ||
CRIS - PSTV | 26% Poorly correlated | -3.27% | ||
SPRB - PSTV | 26% Poorly correlated | +0.44% | ||
More |